Araştırma Makalesi

Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods

Cilt: 7 Sayı: 1 29 Haziran 2026
PDF İndir
EN TR

Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods

Öz

In this study, using the financial data of 12 Turkish and global pharmaceutical companies for the period 2021–2025 and the most commonly used financial performance metrics in the literature, the weights of these metrics were first calculated using the LOPCOW and MEREC methods. Once the metric weights had been determined, the companies’ financial performance was analysed using the EDAS and CoCoSo methods. The results of the performance analysis were evaluated comparatively. When selecting companies for the study, care was taken to include firms from developed countries, emerging markets, manufacturers, distributors, and biotechnology-focused firms. In selecting the criteria to determine the companies’ financial performance, those deemed critical for the pharmaceutical sector were chosen. For the selection of the analysis period, the post-pandemic transformation and the use of current data were chosen. According to the joint weighting results obtained using the LOPCOW and MEREC methods, the most important criterion was identified as C1 (Return on Assets (ROA)) in 2021, C5 (Debt to Equity Ratio (D/E)) in 2022, C1 (Return on Assets (ROA)) in 2023, and C4 (Current Ratio (CR)), and C4 (Current Ratio (CR)) in 2025. According to the EDAS and CoCoSo methods, AstraZeneca and Selçuk Ecza Deposu were found to have the poorest financial performance in the 2021–2025 ranking. Conversely, according to the EDAS and CoCoSo methods, Roche and EIS Eczacıbaşı İlaç were found to have demonstrated the best performance in the financial performance ranking for the period 2021–2025

Anahtar Kelimeler

Kaynakça

  1. Akgün, A., & Ahmadzada, A. (2022). Covid 19 Salgın Döneminde Borsa İstanbul'da İşlem Gören İlaç Firmalarının Finansal Performanslarının Analizi. Muhasebe ve Finans İncelemeleri Dergisi, 5(2), pp. 97-114. https://doi.org/10.32951/mufider.109268
  2. Apan, M., & Öztel, A. (2020). Bütünleşik Entropi-EDAS Yöntemi ile Nakit Akım Odaklı Finansal Performans Analizi: BIST Orman, Kâğıt, Basım Endeksi’nde İşlem Gören Firmaların 2011-2018 Dönem Verisinden Kanıtlar. Bartın Orman Fakültesi Dergisi, 22(1), 170-184. https://doi.org/10.24011/barofd.694820
  3. Ari, H. (2023). DuPont modeli ile bir özel hastane grubunun ve türkiye özel hastaneler sektörünün finansal performansının analizi. İşletme Araştırmaları Dergisi, 15(1), pp. 187-201. https://doi.org/10.20491/isarder.2023.1580
  4. Ayçin, E. (2019). Çok Kriterli Karar Verme: Bilgisayar Uygulamalı Çözümler. Nobel Akademik Yayıncılık. Bektaş, S. (2022). Türk Sigorta Sektörünün 2002-2021 Dönemi İçin MEREC, LOPCOW, COCOSO, EDAS ÇKKV Yöntemleri ile Performansının Değerlendirilmesi. BDDK Bankacılık ve Finansal Piyasalar Dergisi, 16(2), 247-283. https://doi.org/10.46520/bddkdergisi.1178359
  5. Bouraima, M. B., Qiu, Y., Stević, Ž., & Simić, V. (2023). Assessment of Alternative Railway Systems for Sustainable Transportation Using an Integrated IRN SWARA and IRN COCOSO Model. Socio- Economic Planning Sciences, 86, 101475. Retrieved from https://doi.org/10.1016/j.seps.2022.101475
  6. Çelik, M., & Dursun, G. D. (2021). Z skor modeli ile finansal risk tahmini ve BIST100 tekstil, giyim eşyası ve deri imalat sanayi sektöründe faaliyet gösteren firmalar üzerine bir uygulama. İktisadi İdari ve Siyasal Araştırmalar Dergisi, 6(14), pp. 19-31. https://doi.org/10.25204/iktisad.786034
  7. Dhruva, S. K., Zavadskas, E. K., Ravichandran, K. S., & Gandomi, A. H. (2024). Selection of Suitable Cloud Vendors for Health Centre: A Personalized Decision Framework with Fermatean Fuzzy Set, LOPCOW, and COCOSO. Informatica, 35(1), 65-98. https://doi.org/10.15388/23-INFOR537.
  8. Ecer, F., & Güneş, E. (2024). G7 Ülkelerinin Bilgi İletişim Teknoloji Düzeylerini Belirleme: MEREC-CRITIC Entegre Ağırlıklı COCOSO Metodolojisi. Journal of Mehmet Akif Ersoy University Economics and Administrative Sciences Faculty, 11(1), 219-242. doi:https://doi.org/10.30798/makuiibf.1281607

Ayrıntılar

Birincil Dil

İngilizce

Konular

Finans, Finans ve Yatırım (Diğer), Uluslararası Risk Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

29 Haziran 2026

Gönderilme Tarihi

26 Mayıs 2026

Kabul Tarihi

26 Haziran 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 7 Sayı: 1

Kaynak Göster

APA
Özdil, Z., & Özdil, S. (2026). Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods. Journal of Business and Trade, 7(1), 16-35. https://doi.org/10.58767/joinbat.1959292
AMA
1.Özdil Z, Özdil S. Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods. JOINBAT. 2026;7(1):16-35. doi:10.58767/joinbat.1959292
Chicago
Özdil, Zafer, ve Sudenaz Özdil. 2026. “Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods”. Journal of Business and Trade 7 (1): 16-35. https://doi.org/10.58767/joinbat.1959292.
EndNote
Özdil Z, Özdil S (01 Haziran 2026) Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods. Journal of Business and Trade 7 1 16–35.
IEEE
[1]Z. Özdil ve S. Özdil, “Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods”, JOINBAT, c. 7, sy 1, ss. 16–35, Haz. 2026, doi: 10.58767/joinbat.1959292.
ISNAD
Özdil, Zafer - Özdil, Sudenaz. “Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods”. Journal of Business and Trade 7/1 (01 Haziran 2026): 16-35. https://doi.org/10.58767/joinbat.1959292.
JAMA
1.Özdil Z, Özdil S. Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods. JOINBAT. 2026;7:16–35.
MLA
Özdil, Zafer, ve Sudenaz Özdil. “Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods”. Journal of Business and Trade, c. 7, sy 1, Haziran 2026, ss. 16-35, doi:10.58767/joinbat.1959292.
Vancouver
1.Zafer Özdil, Sudenaz Özdil. Comparative Financial Performance Analysis of Turkish and Global Pharmaceutical Companies with MCDM Methods. JOINBAT. 01 Haziran 2026;7(1):16-35. doi:10.58767/joinbat.1959292